HALOZYME THERAPEUTICS, INC. Insider Trading for February 2021

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in HALOZYME THERAPEUTICS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in HALOZYME THERAPEUTICS, INC. for February 2021.

<<< Back to the month list

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 22 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM0.008,80300
Feb 22 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Payment of ExerciseF48.694,364212,483141,124145.5 K to 141.1 K (-3.00 %)
Feb 22 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM0.008,8030145,488136.7 K to 145.5 K (+6.44 %)
Feb 22 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0039,35400
Feb 22 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF48.6919,511949,991537,160556.7 K to 537.2 K (-3.50 %)
Feb 22 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0039,3540556,671517.3 K to 556.7 K (+7.61 %)
Feb 17 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseA0.0013,544013,544
Feb 17 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseA49.8423,3111,161,82023,311
Feb 17 2021GYHTHALOZYME THERAPEUT ...Sun Elaine DSVP, Chief Financia ...Option ExerciseA0.0014,898014,898
Feb 17 2021GYHTHALOZYME THERAPEUT ...Sun Elaine DSVP, Chief Financia ...Option ExerciseA49.8425,6421,277,99725,642
Feb 17 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseA0.0052,368052,368
Feb 17 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseA49.8490,1344,492,27990,134
Feb 16 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0028,729028,729
Feb 16 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF49.8414,243709,871517,317531.6 K to 517.3 K (-2.68 %)
Feb 16 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0028,7290531,560502.8 K to 531.6 K (+5.71 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseM0.004,12908,258
Feb 12 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Option ExerciseM0.006,257018,769
Feb 12 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Payment of ExerciseF49.842,047102,02216,57818.6 K to 16.6 K (-10.99 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...BuyM0.004,129018,62514.5 K to 18.6 K (+28.48 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...Payment of ExerciseF50.603,203162,07214,49617.7 K to 14.5 K (-18.10 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...Matsuda MasaruSVP, General Counse ...BuyM0.006,257017,69911.4 K to 17.7 K (+54.68 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM0.007,883015,766
Feb 12 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Option ExerciseM0.008,134024,399
Feb 12 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Payment of ExerciseF49.842,725135,814133,186135.9 K to 133.2 K (-2.00 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM0.007,8830135,911128 K to 135.9 K (+6.16 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...Payment of ExerciseF50.602,906147,044128,028130.9 K to 128 K (-2.22 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...LaBarre Michael J.SVP, Chief Technica ...BuyM0.008,1340130,934122.8 K to 130.9 K (+6.62 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0032,795065,589
Feb 12 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM0.0031,282093,844
Feb 12 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF49.8416,259810,349502,831519.1 K to 502.8 K (-3.13 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0032,7950519,090486.3 K to 519.1 K (+6.74 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOPayment of ExerciseF50.6015,509784,755486,295501.8 K to 486.3 K (-3.09 %)
Feb 12 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM0.0031,2820501,804470.5 K to 501.8 K (+6.65 %)
Feb 01 2021GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorSellS48.6924611,977189,833190.1 K to 189.8 K (-0.13 %)
Feb 01 2021GYHTHALOZYME THERAPEUT ...Kelley Kenneth JDirectorSellS48.094,754228,617190,079194.8 K to 190.1 K (-2.44 %)
Feb 01 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOOption ExerciseM14.6650,000733,000600,000
Feb 01 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOSellS48.515,437263,736470,522476 K to 470.5 K (-1.14 %)
Feb 01 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOSellS47.7644,5632,128,182475,959520.5 K to 476 K (-8.56 %)
Feb 01 2021GYHTHALOZYME THERAPEUT ...Torley HelenPresident and CEOBuyM14.6650,000733,000520,522470.5 K to 520.5 K (+10.63 %)

Contact us | Follow us on Twitter